Effects of t-DCS and Cognitive Training on Apathy in Elderly With Minor Neurocognitive Impairment
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Jan 31, 2022
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique using a low intensity electric current to modify cortical excitability. There is growing interest for tDCS for psychiatric illnesses, notably for depression.
Apathy is a pervasive neuropsychiatric symptom characterized by a reduction in goal-directed behavior and activity that persists over time and causes identifiable functional impairment. tDCS could be a promising new area for non-pharmacological treatment of apathy.
The aim of this study is to evaluate the effects of repeated sessions of tDCS ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 65 years
- • Subject consulting in one of the investigating centers
- • Clinical diagnosis of Minor Neurocognitive Disorder according to DSM 5 criteria (APA, 2013)
- • Apathetic syndrome defined according to the Diagnostic Criteria for Apathy (Miller \& al., 2021)
- • Subject who can read and write French
- • Subjects who are beneficiaries of a social security plan
- • Signature of free and informed consent
- Exclusion Criteria:
- • Current clinical diagnosis of a depressive episode characterized by DSM 5 criteria (APA, 2013)
- • Known diagnosis of schizophrenia, bipolar disorder, substance abuse or dependence
- • Significant sensory or motor impairment
- • Subject under guardianship, conservatorship, or conservatorship
- • Active smoking or smoking cessation of less than one year
- • Contraindications to the practice of tDCS: history of intracranial hypertension, neurosurgery, metallic implant at the cephalic level, pacemaker
- • Unbalanced epilepsy
- • Severe somatic disease not stabilized
- • Previous use of tDCS (problem of maintaining the integrity of the blinding procedure)
- • Scalp skin disease
- • Concurrent participation in another drug research study or any other study that may interfere with study results
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Patients applied
Trial Officials
Eric ETTORE, MD
Principal Investigator
Nice University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials